
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc.(ALDX)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · ALDX · 截至 2026年6月8日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
2
近12个月
买卖比
2.00
Buy/Sell (by trades)
整体情绪
Aldeyra Therapeutics, Inc.内部人在过去近12个月净买入股份,可能反映对公司前景的信心。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ALDX 季度内部人买卖趋势
ALDX 内幕交易卖出 · ALDX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ALDX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ALDX 高管卖出股份 · ALDX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 3, 2026 | Brady Todd C President and CEO · Director | Purchase | 250,000 | $418K | Form 4 |
| Mar 19, 2026 | DOUGLAS RICHARD Director | Purchase | 70,000 | $98K | Form 4 |
| Mar 18, 2026 | Alfieri Michael Principal Financial Officer | Purchase | 5,000 | $7K | Form 4 |
| Aug 13, 2025 | Alfieri Michael Principal Financial Officer | Purchase | 2,500 | $13K | Form 4 |
| Aug 11, 2025 | Machatha Stephen Chief Development Officer | Sale | 22,073 | $114K | Form 4 |
| Apr 3, 2025 | PERCEPTIVE ADVISORS LLC 10 percent owner | Sale | 3,400,000 | $4.83M⚡ | Form 4 |
| Apr 12, 2023 | Miller-Rich Nancy Director | Purchase | 509 | $5K | Form 4 |
| May 3, 2021 | Miller-Rich Nancy Director | Purchase | 413 | $5K | Form 4 |
| Aug 12, 2024 | Machatha Stephen Chief Development Officer | Sale | 16,041 | $76K | Form 4 |
| Aug 12, 2024 | Greenberg Bruce See Remarks | Sale | 10,834 | $51K | Form 4 |
| Apr 5, 2024 | PERCEPTIVE ADVISORS LLC 10 percent owner | Purchase | 37,712 | $179K | Form 4 |
| Apr 4, 2024 | PERCEPTIVE ADVISORS LLC 10 percent owner | Purchase | 140,281 | $655K | Form 4 |
| Apr 3, 2024 | PERCEPTIVE ADVISORS LLC 10 percent owner | Purchase | 309,847 | $1.27M⚡ | Form 4 |
| Apr 2, 2024 | PERCEPTIVE ADVISORS LLC 10 percent owner | Purchase | 186,051 | $640K | Form 4 |
| Apr 1, 2024 | PERCEPTIVE ADVISORS LLC 10 percent owner | Purchase | 8,374 | $27K | Form 4 |
| Mar 11, 2024 | Greenberg Bruce See Remarks | Sale | 13,201 | $45K | Form 4 |
| Mar 11, 2024 | Machatha Stephen Chief Development Officer | Sale | 18,231 | $62K | Form 4 |
| Mar 12, 2024 | Machatha Stephen Chief Development Officer | Sale | 11,537 | $37K | Form 4 |
| Mar 11, 2024 | Brady Todd C President and CEO · Director | Sale | 97,914 | $321K | Form 4 |
| Mar 12, 2024 | Brady Todd C President and CEO · Director | Sale | 85,324 | $260K | Form 4 |
| Oct 16, 2023 | PERCEPTIVE ADVISORS LLC 10 percent owner | Sale | 2,450,000 | $3.92M⚡ | Form 4 |
| Oct 18, 2023 | PERCEPTIVE ADVISORS LLC 10 percent owner | Sale | 306,499 | $533K | Form 4 |
| Sep 7, 2023 | Brady Todd C President and CEO · Director | Option | 48,021 | $27K | Form 4 |
| Sep 7, 2023 | Brady Todd C President and CEO · Director | Option | 32,953 | $18K | Form 4 |
| Sep 7, 2023 | Brady Todd C President and CEO · Director | Other | 73,807 | $533K | Form 4 |
Brady Todd C
President and CEO · Director
日期
Jun 3
股数
250,000
均价
$1.67
总金额
$418K
Alfieri Michael
Principal Financial Officer
日期
Mar 18
股数
5,000
均价
$1.42
总金额
$7K
Alfieri Michael
Principal Financial Officer
日期
Aug 13
股数
2,500
均价
$5.30
总金额
$13K
PERCEPTIVE ADVISORS LLC
10 percent owner
日期
Apr 3
股数
3,400,000
均价
$1.42
总金额
$4.83M ⚡
PERCEPTIVE ADVISORS LLC
10 percent owner
日期
Apr 4
股数
140,281
均价
$4.67
总金额
$655K
PERCEPTIVE ADVISORS LLC
10 percent owner
日期
Apr 3
股数
309,847
均价
$4.09
总金额
$1.27M ⚡
PERCEPTIVE ADVISORS LLC
10 percent owner
日期
Apr 2
股数
186,051
均价
$3.44
总金额
$640K
PERCEPTIVE ADVISORS LLC
10 percent owner
日期
Oct 16
股数
2,450,000
均价
$1.60
总金额
$3.92M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ALDX 内幕交易
ALDX 内幕交易
Aldeyra Therapeutics, Inc.(ALDX)内幕交易数据来源于公司内部人(包括Alfieri Michael (Principal Financial Officer), Brady Todd C (President and CEO · Director), DOUGLAS RICHARD (Director))提交的SEC Form 4申报文件。过去12个月内,4位内部人向SEC提交了交易申报。ALDX内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Aldeyra Therapeutics, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
ALDX 内幕交易 · 5个问题Aldeyra Therapeutics, Inc.(ALDX)的内部人包括高管和董事,如Alfieri Michael (Principal Financial Officer), Brady Todd C (President and CEO · Director), DOUGLAS RICHARD (Director)等。过去12个月内,4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026